RAF Proto Oncogene Serine/Threonine Protein Kinase Pipeline Report: Guide Features Descriptive Drug Profiles & Other Developmental Activities
The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and indus
(EMAILWIRE.COM, April 03, 2018 ) RAF Proto Oncogene Serine/Threonine Protein Kinase (Proto Oncogene c RAF or RAF1 or EC 2.7.11.1) - RAF proto-oncogene serine/threonine-protein kinase or proto-oncogene c-RAF is an enzyme is encoded by the RAF1 gene. Once activated the cellular RAF1 protein can phosphorylate to activate the dual specificity protein kinases MEK1 and MEK2 which in turn phosphorylate to activate the serine/threonine specific protein kinases, ERK1 and ERK2. It plays an important role in the control of gene expression involved in the cell division cycle, apoptosis, cell differentiation and cell migration.
Report Source: https://www.themarketreports.com/report/raf-proto-oncogene-serinethreonine-protein-kinase-proto-oncogene-c-raf-or-raf1-or-ec-27111-pipeline-review-h1-2018
Scope
• The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
• The report reviews key players involved in RAF Proto Oncogene Serine/Threonine Protein Kinase (Proto Oncogene c RAF or RAF1 or EC 2.7.11.1) targeted therapeutics and enlists all their major and minor projects
• The report assesses RAF Proto Oncogene Serine/Threonine Protein Kinase (Proto Oncogene c RAF or RAF1 or EC 2.7.11.1) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
• The report summarizes all the dormant and discontinued pipeline projects
• The report reviews latest news and deals related to RAF Proto Oncogene Serine/Threonine Protein Kinase (Proto Oncogene c RAF or RAF1 or EC 2.7.11.1) targeted therapeutics
Purchase this report at: https://www.themarketreports.com/report/buy-now/968361
Companies Mentioned
• Basilea Pharmaceutica Ltd
• CBT Pharmaceuticals Inc
• Chugai Pharmaceutical Co Ltd
• Hanmi Pharmaceuticals Co Ltd
• Millennium Pharmaceuticals Inc
• Novartis AG
• Redx Pharma Plc
• VG Life Sciences Inc
Got a question; ask us at: https://www.themarketreports.com/report/ask-your-query/968361
Report Source: https://www.themarketreports.com/report/raf-proto-oncogene-serinethreonine-protein-kinase-proto-oncogene-c-raf-or-raf1-or-ec-27111-pipeline-review-h1-2018
Scope
• The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
• The report reviews key players involved in RAF Proto Oncogene Serine/Threonine Protein Kinase (Proto Oncogene c RAF or RAF1 or EC 2.7.11.1) targeted therapeutics and enlists all their major and minor projects
• The report assesses RAF Proto Oncogene Serine/Threonine Protein Kinase (Proto Oncogene c RAF or RAF1 or EC 2.7.11.1) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
• The report summarizes all the dormant and discontinued pipeline projects
• The report reviews latest news and deals related to RAF Proto Oncogene Serine/Threonine Protein Kinase (Proto Oncogene c RAF or RAF1 or EC 2.7.11.1) targeted therapeutics
Purchase this report at: https://www.themarketreports.com/report/buy-now/968361
Companies Mentioned
• Basilea Pharmaceutica Ltd
• CBT Pharmaceuticals Inc
• Chugai Pharmaceutical Co Ltd
• Hanmi Pharmaceuticals Co Ltd
• Millennium Pharmaceuticals Inc
• Novartis AG
• Redx Pharma Plc
• VG Life Sciences Inc
Got a question; ask us at: https://www.themarketreports.com/report/ask-your-query/968361
Contact Information:
The Market Reports
Shirish Gupta
Tel: +1-631-407-1315
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
The Market Reports
Shirish Gupta
Tel: +1-631-407-1315
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results